NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / World

Used in Covid shots, mRNA may help rid the body of HIV

By Apoorva Mandavilli
New York Times·
8 Jun, 2025 05:00 PM5 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Australian researchers used mRNA to coax HIV out of hiding, a key step towards a cure. Photo / Joe Raedle, Getty Images

Australian researchers used mRNA to coax HIV out of hiding, a key step towards a cure. Photo / Joe Raedle, Getty Images

The technology that powered Covid-19 vaccines may also lead scientists to a cure for HIV.

Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely.

The research, published in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab.

But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries.

Short for messenger RNA, mRNA is a set of instructions for a gene.

Advertisement
Advertise with NZME.

In the case of Covid vaccines, the instructions were for a piece of the coronavirus.

In the new study, they are for molecules key to targeting HIV.

Dr Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a “miraculous” tool “to deliver things that you want into places that were not possible before”.

Advertisement
Advertise with NZME.

Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body’s immune response.

In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear.

Some American officials, including Health Secretary Robert F. Kennedy jnr, have falsely said that they are highly dangerous and even deadly.

The researchers plan to test the method in HIV-infected animals before moving to clinical trials. Photo / Joe Raedle, Getty Images
The researchers plan to test the method in HIV-infected animals before moving to clinical trials. Photo / Joe Raedle, Getty Images

The US Department of Health and Human Services has sought to limit the vaccine’s availability to pregnant women, children and healthy younger adults.

A week ago the Trump Administration cancelled a nearly US$600 million ($997m) contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu.

“The fear right now is not rational,” Lewin said, adding that “mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks”.

The new study describes the use of mRNA as a tool to flush HIV out of its hiding places.

Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors.

Advertisement
Advertise with NZME.

Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a “promising, absolutely powerful technology”.

Although most people may have only heard of mRNA’s use in science during the pandemic, scientists have been working with it for more than 20 years, she said.

“I think it’s not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,” she added.

Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels.

Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge.

A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called “shock and kill”.

HIV cure potential: mRNA study reveals breakthrough in virus activation. Photo / Getty Images
HIV cure potential: mRNA study reveals breakthrough in virus activation. Photo / Getty Images

A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs.

The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects.

“It’s fair to say the field’s been a little bit stuck,” said Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research.

In 2022, Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.)

“You get just a little bit of a gentle nudge with some of these vaccines, and it’s enough to coax some of these latent viruses out so they can be killed,” Jones said.

Lewin and her colleagues had for years experimented with other ways to activate HIV but had no luck in resting cells.

Seeing the success of the Covid vaccines, which used lipid nanoparticles – tiny spheres of fat – containing mRNA, her team tested similar particles.

They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can “edit” genes.

The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy.

The method will be tested in HIV-infected animals before clinical trials. Photo / Getty Images
The method will be tested in HIV-infected animals before clinical trials. Photo / Getty Images

“It’s very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,” Muecksch said.

It’s unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce.

Lewin said that “mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug”.

In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives.

The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials.

This article originally appeared in The New York Times.

Written by: Apoorva Mandavilli

Photographs by: Joe Raedle

©2025 THE NEW YORK TIMES

Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Latest from World

World

10 people dead in Austria school shooting

10 Jun 09:34 AM
World

'Very stressed': Alleged poisoner disputes claims in court

10 Jun 07:54 AM
World

'Footage was horrific': Albanese reacts after Australian journalist shot by US police

10 Jun 07:00 AM

Why Cambridge is the new home of future-focused design

sponsored
Advertisement
Advertise with NZME.

Latest from World

10 people dead in Austria school shooting

10 people dead in Austria school shooting

10 Jun 09:34 AM

The suspected attacker is said to be among the dead.

'Very stressed': Alleged poisoner disputes claims in court

'Very stressed': Alleged poisoner disputes claims in court

10 Jun 07:54 AM
'Footage was horrific': Albanese reacts after Australian journalist shot by US police

'Footage was horrific': Albanese reacts after Australian journalist shot by US police

10 Jun 07:00 AM
Trump orders active-duty Marines into LA amid immigration arrest protests

Trump orders active-duty Marines into LA amid immigration arrest protests

Clean water fuelling Pacific futures
sponsored

Clean water fuelling Pacific futures

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • What the Actual
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven CarGuide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP